Elsevier

Progress in Neurobiology

Volume 154, July 2017, Pages 37-61
Progress in Neurobiology

Review article
Granin-derived peptides

https://doi.org/10.1016/j.pneurobio.2017.04.003Get rights and content

Highlights

  • The chromogranins are proteolytically processed.

  • The processing leads to the generation of peptides.

  • Among them, VS, CST, PST and SN are biologically highly active.

  • For several other peptides the function must be explored.

Abstract

The granin family comprises altogether 7 different proteins originating from the diffuse neuroendocrine system and elements of the central and peripheral nervous systems. The family is dominated by three uniquely acidic members, namely chromogranin A (CgA), chromogranin B (CgB) and secretogranin II (SgII). Since the late 1980s it has become evident that these proteins are proteolytically processed, intragranularly and/or extracellularly into a range of biologically active peptides; a number of them with regulatory properties of physiological and/or pathophysiological significance. The aim of this comprehensive overview is to provide an up-to-date insight into the distribution and properties of the well established granin-derived peptides and their putative roles in homeostatic regulations. Hence, focus is directed to peptides derived from the three main granins, e.g. to the chromogranin A derived vasostatins, betagranins, pancreastatin and catestatins, the chromogranin B-derived secretolytin and the secretogranin II-derived secretoneurin (SN). In addition, the distribution and properties of the chromogranin A-derived peptides prochromacin, chromofungin, WE14, parastatin, GE-25 and serpinins, the CgB-peptide PE-11 and the SgII-peptides EM66 and manserin will also be commented on. Finally, the opposing effects of the CgA-derived vasostatin-I and catestatin and the SgII-derived peptide SN on the integrity of the vasculature, myocardial contractility, angiogenesis in wound healing, inflammatory conditions and tumors will be discussed.

Introduction

The granin family of uniquely acidic proteins comprises three main members, i.e. chromogranin (CgA), chromogranin B (CgB) and secretogranin II (SgII). These proteins are expressed in central and peripheral neurons and in neuronal and non-neuronal endocrine tissues (see reviews by Huttner et al., 1991; Winkler and Fischer-Colbrie, 1992, Fischer-Colbrie et al., 1995, Helle, 2004, Montero-Hadjadje et al., 2008, Borges et al., 2013). They are also present in cells and tissues such as in polymorphonuclear neutrophils (Helle, 2010a), the myocardium (Yoo, 2012), a variety of tumors (D’Herbomez et al., 2016) as well as in saliva (Mizuhashi et al., 2015, Kogawa et al., 2016) and in the circulation (Yang et al., 2015). The human CgA, CgB and SgII are targeted by a range of intra- and extracellular proteases, cleaving at multiple sites in the amino acid sequences, e.g. at 12, 18 and 9 pairs of basic amino acids in CgA, CgB and SgII, respectively (Huttner et al., 1991, Portela-Gomes et al., 2010). The first granin–derived peptide was described in 1987 when the insulin release inhibiting peptide pancreastatin was identified as the midsection of CgA (Fig. 1) (Huttner and Benedum, 1987, Schmidt et al., 1988), making it likely that not only CgA, but also CgB (Fig. 2) and SgII (Fig. 3) might serve as prohormones for biologically active peptides (Eiden, 1987).

The functional roles of the granin-derived peptides are diverse. Not only do they play important functions in the formation of secretory granules (Chanat and Huttner, 1991, Gerdes and Glombik, 2000, Montero-Hadjadje et al., 2008) and in costorage and corelease of catecholamines (Banks and Helle, 1965, Blaschko et al., 1967, Borges et al., 2013, Estevéz-Herrera et al., 2016); they also exert regulatory effects on the protection against microbial invasions (Metz-Boutigue et al., 1998), on the integrity of the vasculature (Ferrero et al., 2004), on myocardial contractility (Angelone et al., 2008), on angiogenesis in wound healing (Crippa et al., 2013) and in tumors (Bianco et al., 2016a, Bianco et al., 2016b, Curnis et al., 2016) as well as in inflammatory diseases (Zhang et al., 2009). Although both CgA and CgB each play significant roles in the accumulation and exocytosis of the catecholamines, the lack of both proteins in double knockout mice reduces vesicular amine content to half while other proteins, such as fibrinogen, appear to compensate for the absence of the granins in the secretory pathway (Diaz-Vera et al., 2012). Moreover, the lack of both granins markedly reduced responses to stress and exerted hypersensitivity to insulin as well as increases in aggressive behaviour (Pereda et al., 2015).

Section snippets

Processing of granins by intra- and extracellular proteases

The mammalian prohormone convertases (PCs) are serine proteinases related to the bacterial-subtilisin/yeast-kexin PC family (Seidah and Chretien, 1999). Importantly, PC1/3 and PC2, cleaving at single or pairs of basic amino acids, are specific for intragranular processing in neuroendocrine tissues (Eskeland et al., 1996, Udupi et al., 1999, Doblinger et al., 2003, Von Eggelkraut-Gottanka and Beck-Sickinger, 2004). In addition, also furin and cathepsin L are colocalized with granins in secretory

The CgA-derived peptides

As discussed above and illustrated in Fig. 1, CgA is subject to an extensive degree of intra- and extracellular proteolytic processing by cleavage at multiple dibasic sites, notably at the N- and C-terminal regions (Metz-Boutigue et al., 1993).

CgB-derived peptides

At the N-terminus of CgB (Fig. 2) the cysteine loop-containing peptide CgB1–41 (Russell et al., 1994) was shown to inhibit parathormone release analogous to the VS-I-derived CgA1–40 (Fig. 1). BAM-1745 (bCgB547–560) was the first peptide to be isolated from the C-terminal side (Flanagan et al., 1990). Soon thereafter the antimicrobial secretolytin (CgB614–626) was reported (Strub et al., 1995). Moreover, a BAM-like peptide PE-11 (rCgB552–562) in the rat brain (Krösen et al., 1996) appears also

Sg II-derived peptides

SgII, comprising 613, 617 and 619 amino acid residues in the bovine, human and rat homolouges (Fig. 3), is a member of the tyrosine-sulphated granin family (Gerdes et al., 1989, Huttner et al., 1991). Yet, processing has so far generated only one biologically active peptide, i.e. the 33 residue long peptide secretoneurin (SN, SgII154–186), the name reflecting its relative abundance in neuronal tissues (Kirchmair et al., 1993, Kirchmair et al., 1994). SgII was first localized in normal rat

Granin peptides in a sense organ

The only sense organ yet to be explored for several of the granin-derived peptides is the eye. Not only the biologically active peptides, such as the CgA-derived CST and the SgII-derived SN, but also the inert peptides including the CgA-derived fragments WE-14, GE-25 and the CgB peptide PE-11, have provided valuable information on the distribution of granin-positive nerve fibers and cell bodies in ocular tissues. All these peptides are present in the retina and also in tissues innervated by the

Comparison of effects of VS-I, CST and SN

The literature reviewed above on the functional effects of granin-derived peptides points to particular impacts of a few, namely the CgA-derived VS-I and CST and the SgII derived SN. As summarized in Table 2, VS-I appears to have opposite effects to those of CST and/or SN on several vital functions, such as cell adhesion, chemotaxis and proliferation and on angiogenesis and endothelial integrity under normal and/or pathological conditions. Yet, only VS-I and CST appear to exert cardioprotection

Summing up and concluding remarks

Data accumulated since the mid 1980s are consistent with the concept of the three main granins, CgA, CgB and SgII serving as prohormones for a wide range of biologically active peptides, some of them with physiological and/or pathophysiological significance. Proteolytic cleavage occurs in species- and tissue-specific patterns, intracellularly and extracellularly, and the resulting granin-derived peptides are widely distributed, also in species- and tissue-specific patterns. For example, in a

References (417)

  • A. Blois et al.

    Interactions of chromogranin A-derived vasostatins and monolayers of phosphatidylserine, phosphatidylcholine and phosphatidylethanolamine

    Regul. Pept.

    (2006)
  • A. Blois et al.

    The chromogranin A peptide vasostatin-I inhibits gap formation and signal transduction mediated by inflammatory agents in cultured bovine pulmonary and coronary arterial endothelial cells

    Regul. Pept.

    (2006)
  • M. Bloomston et al.

    Hepatic artery chemoembolization in 122 patients with metastatic carcinoid tumor: lessons learned

    J. Gastrointest. Surg.

    (2007)
  • R. Borges et al.

    Granins and catecholamines: functional interaction in chromaffin cells and adipose tissue

    Adv. Pharmacol.

    (2013)
  • M. Boutahricht et al.

    Immunohistochemical distribution of the secretogranin II-derived peptide EM66 in the rat hypothalamus: a comparative study with jerboa

    Neurosci. Lett.

    (2007)
  • J.F. Brekke et al.

    N-terminal chromogranin-derived peptides as dilators of bovine coronary resistance arteries

    Regul. Pept.

    (2002)
  • J. Ciesielski-Treska et al.

    Chromogranin A induces a neurotoxic phenotype in brain microglial cells

    J. Biol.

    (1998)
  • K. Cima et al.

    Sensory neuropeptides are potent chemoattractants for human basophils in vitro

    Regul. Pept.

    (2010)
  • D.V. Cohn et al.

    Chromogranin A: a novel regulator of parathyroid gland secretion

    J. Nutr.

    (1995)
  • B. Colombo et al.

    Cleavage of chromogranin A N-terminal domain by plasmin provides a new mechanism for regulating cell adhesion

    J. Biol. Chem.

    (2002)
  • J.M. Conlon et al.

    Isolation of peptides arising from the specific posttranslational processing of chromogranin A and B from human pheochromocytoma tissue

    Peptides

    (1992)
  • J.M. Conlon

    Granin-derived peptides as diagnostic and prognostic markers for endocrine tumors

    Regul. Pept.

    (2010)
  • L. Crippa et al.

    A new chromogranin A-dependent angiogenic switch activated by thrombin

    Blood

    (2013)
  • W.J. Curry et al.

    Isolation and primary structure of a novel chromogranin A-derived peptide, WE-14, from a human midgut carcinoid tumour

    FEBS Lett.

    (1992)
  • W.J. Curry et al.

    Characterisation of WE-14 in porcine ocular tissue

    Regul. Pept.

    (2003)
  • L.J. Deftos et al.

    Distinct patterns of chromogranin A-related species can be demonstrated in endocrine cells

    Bone Miner.

    (1990)
  • J. Depreitere et al.

    Presence and release of SR-17 (chromogranin B (586–602)) in the porcine splenic nerve and ist enzymatic degradation by CD26 dipeptidyl peptidase IV

    Regul. Pept.

    (2002)
  • J. Depreitere et al.

    Presence and release of the chromogranin B-derived secretolytin-like peptide KR-11 from the porcine spleen

    Regul. Pept.

    (2004)
  • S. Díaz-Troya et al.

    eNOS, nNOS, cGMP and protein kinase G mediate the inhibitory effect of pancreastatin, a chromogranin A-derived peptide, on growth and proliferation of hepatoma cells

    Regul. Pept.

    (2005)
  • A. Doblinger et al.

    Proteolytic processing of chromogranin A by the prohormone convertase PC2

    Regul. Pept.

    (2003)
  • B.M. Drees et al.

    Pancreastatin and bovine parathyroid cell secretion

    Bone Miner.

    (1992)
  • S. Dunzendorfer et al.

    Secretoneurin, a novel neuropeptide, is a potent chemoattractant for human eosinophils

    Blood

    (1998)
  • U. Eder et al.

    Level and molecular forms of chromogranins in human childhood neuroblastomas and ganglioneuromas

    Neurosci. Lett.

    (1998)
  • S. Aardal et al.

    Vasostatins, comprising the N-terminal domain of chromogranin A, suppress tension in isolated human blood vessel segments

    J. Neuroendocrinol.

    (1993)
  • K. Albrecht-Schgoer et al.

    The angiogenic factor secretoneurin induces coronary angiogenesis in a model of myocardial infarction by stimulation of vascular endothelial growth factor signalling in endothelial cells

    Circulation

    (2012)
  • K. Albrecht-Schgoer et al.

    Topical secretoneurin gene therapy accelerates diabetic wound healing by interaction between heparan-sulfate proteoglycans and basic FGF

    Angiogenesis

    (2014)
  • R.H. Angeletti et al.

    Vasoinhibitory activity of synthetic peptides from the aminoterminus of chromogranin A

    Acta Physiol. Scand.

    (1994)
  • R.H. Angeletti et al.

    Determination of residues in chromogranin A (16–40) required for inhibition of parathyroid hormone secretion

    Endocrinology

    (1996)
  • T. Angelone et al.

    The antihypertensive chromogranin A peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropism

    Endocrinology

    (2008)
  • T. Angelone et al.

    Chromogranin A: a multifaceted cardiovascular role in health and disease

    Curr. Med. Chem.

    (2012)
  • Y. Anouar et al.

    Identification of a novel secretogranin II-derived peptide (SgII187-252) in adult and fetal human adrenal glands using antibodies raised against the human recombinant peptide

    J. Clin. Endocrinol. Metab.

    (1998)
  • T. Asahara et al.

    Isolation of putative progenitor endothelial cells for angiogenesis

    Science

    (1997)
  • R. Aslam et al.

    Chromogranin A-derived peptides are involved in innate immunity

    Curr. Med. Chem.

    (2012)
  • G. Aung et al.

    Catestatin, a neuroendocrine antimicrobial peptide, induces human mast cell migration, degranulation and production of cytokines and chemokines

    Immunology

    (2011)
  • D. Aunis et al.

    Chromogranins: current concepts. Structural and functional aspects

    Adv. Exp. Med. Biol.

    (2000)
  • M. Bacaner et al.

    Prevention of ventricular fibrillation, acute myocardial infarction (myocardial necrosis), heart failure, and mortality by bretylium: is ischemic heart disease primarily adrenergic cardiovascular disease?

    Am. J. Ther.

    (2004)
  • D.K. Badyal et al.

    Animal models of hypertension and effect of drugs

    Indian J. Pharmacol.

    (2003)
  • G.K. Bandyopadhyay et al.

    Pancreastatin-dependent inflammatory signaling mediates obesity-induced insulin resistance

    Diabetes

    (2015)
  • P. Banks et al.

    The release of protein from the stimulated adrenal medulla

    Biochem. J.

    (1965)
  • J.A. Barbosa et al.

    Chromogranin A: posttranslational modifications

    Endocrinology

    (1991)
  • Cited by (0)

    View full text